StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

Zivo Bioscience's R&D Expenses for the twelve months ending Sep 30, 2025 was $3.70M, up 15.4% year over year. For fiscal 2024 it was $3.13M, up 127.7% from the year before. Over ten years it grew 4.7% a year on average. The highest annual figure on record is $3.75M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$3.13M+127.7%
FY2023Dec 31, 2023$1.38M-38.5%
FY2022Dec 31, 2022$2.24M+14.9%
FY2021Dec 31, 2021$1.95M-48.1%
FY2020Dec 31, 2020$3.75M+62.8%
FY2019Dec 31, 2019$2.31M-18.0%
FY2018Dec 31, 2018$2.81M+18.2%
FY2017Dec 31, 2017$2.38M+201.8%
FY2016Dec 31, 2016$788.97K-23.6%
FY2015Dec 31, 2015$1.03M-47.6%
FY2014Dec 31, 2014$1.97M+93.6%
FY2013Dec 31, 2013$1.02M+50.3%
FY2012Dec 31, 2012$677.49K+79.3%
FY2011Dec 31, 2011$377.89K-4.5%
FY2010Dec 31, 2010$395.57K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$203.44K-37.7%
Q2 FY2025Jun 30, 2025$479.66K-78.7%
Q1 FY2025Mar 31, 2025$2.77M+785.4%
Q4 FY2024Dec 31, 2024$243.48K-22.1%
Q3 FY2024Sep 30, 2024$326.36K+47.9%
Q2 FY2024Jun 30, 2024$2.25M+409.4%
Q1 FY2024Mar 31, 2024$312.77K-22.2%
Q4 FY2023Dec 31, 2023$312.47K-39.8%
Q3 FY2023Sep 30, 2023$220.65K-63.4%
Q2 FY2023Jun 30, 2023$442.11K+0.9%
Q1 FY2023Mar 31, 2023$401.80K-40.9%
Q4 FY2022Dec 31, 2022$519.35K-3.8%
Q3 FY2022Sep 30, 2022$603.11K+47.5%
Q2 FY2022Jun 30, 2022$438.05K-6.4%
Q1 FY2022Mar 31, 2022$679.77K+5.1%
Q4 FY2021Dec 31, 2021$539.92K+20.7%
Q3 FY2021Sep 30, 2021$409.01K-68.4%
Q2 FY2021Jun 30, 2021$467.92K+7.1%
Q1 FY2021Mar 31, 2021$646.75K-59.0%
Q4 FY2020Dec 31, 2020$447.20K-4.3%
Q3 FY2020Sep 30, 2020$1.29M+146.4%
Q2 FY2020Jun 30, 2020$436.70K-53.9%
Q1 FY2020Mar 31, 2020$1.58M+330.6%
Q4 FY2019Dec 31, 2019$467.49K-16.3%
Q3 FY2019Sep 30, 2019$525.58K-5.3%
Q2 FY2019Jun 30, 2019$947.91K+22.5%
Q1 FY2019Mar 31, 2019$366.06K-60.5%
Q4 FY2018Dec 31, 2018$558.70K-45.6%
Q3 FY2018Sep 30, 2018$555.19K+0.8%
Q2 FY2018Jun 30, 2018$773.99K+56.2%
Q1 FY2018Mar 31, 2018$927.12K+200.0%
Q4 FY2017Dec 31, 2017$1.03M+445.8%
Q3 FY2017Sep 30, 2017$550.55K+338.0%
Q2 FY2017Jun 30, 2017$495.52K+204.5%
Q1 FY2017Mar 31, 2017$309.02K-1.1%
Q4 FY2016Dec 31, 2016$188.01K-27.1%
Q3 FY2016Sep 30, 2016$125.70K–
Q2 FY2016Jun 30, 2016$162.71K–
Q1 FY2016Mar 31, 2016$312.56K–
Q4 FY2015Dec 31, 2015$257.84K–

More Zivo Bioscience figures

See a number that looks wrong?